Pharmacotherapy of ADHD in adults. (Q46529255)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567133 AND SRC:MED&resulttype=core&format=json

9 January 2020

title

Pharmacotherapy of ADHD in adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567133 AND SRC:MED&resulttype=core&format=json

9 January 2020

0 references

Timothy E Wilens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567133 AND SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567133 AND SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567133 AND SRC:MED&resulttype=core&format=json

9 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567133 AND SRC:MED&resulttype=core&format=json

9 January 2020

issue

5 Suppl 8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567133 AND SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

11-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567133 AND SRC:MED&resulttype=core&format=json

Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017/S1092852950002960

7 January 2021

Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study

1 reference

https://api.crossref.org/works/10.1017/S1092852950002960

7 January 2021

Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1017/S1092852950002960

7 January 2021

Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in

1 reference

https://api.crossref.org/works/10.1017/S1092852950002960

7 January 2021

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017/S1092852950002960

7 January 2021

An open-label trial of OROS methylphenidate in adults with late-onset ADHD.

1 reference

https://api.crossref.org/works/10.1017/S1092852950002960

7 January 2021

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1017/S1092852950002960

7 January 2021

Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.

1 reference

https://api.crossref.org/works/10.1017/S1092852950002960

7 January 2021

10.1017/S1092852950002960

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567133 AND SRC:MED&resulttype=core&format=json

9 January 2020

1 reference